Greenwich Lifesciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.1% | +0.1% | +0.0% | +0.0% | +0.0% | -50.7% | |
| – | – | – | +247.8% | -2.6% | +164.0% | +36.4% | +205.0% | -6.2% | |
| – | – | +0.0% | +247.8% | -2.6% | – | – | – | – | |
| – | +8.4% | +86.7% | -99.0% | -1,456.1% | – | – | +3,916.8% | +108.6% | |
| – | – | – | – | – | – | -100.0% | – | +0.0% | |
| – | – | – | – | -89.7% | -342.3% | -100.0% | – | – | |
| – | – | +115.0% | -267.4% | -23.6% | – | – | – | – | |
| – | – | +7.5% | +13,763.5% | -90.5% | -365.8% | -100.0% | – | +174.6% | |
| – | – | -192.0% | – | -105.1% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.